CDK 4/6 inhibitors and stereotactic radiation in the management of hormone receptor positive breast cancer brain metastases.

Nicholas B FiguraThrisha K PotluriHoman MohammadiDaniel E OliverJohn A ArringtonTimothy J RobinsonArnold B EtameNam D TranJames K LiuHatem SolimanPeter A ForsythSolmaz SahebjamH Michael YuHyo S HanKamran A Ahmed

Published in: Journal of neuro-oncology (2019)

Stereotactic radiation to breast brain metastases was well tolerated alongside CDK4/6 inhibitors. Compared to historical data, brain metastases control rates are similar whereas survival appears prolonged.

Keyphrases

brain metastases
small cell lung cancer
positive breast cancer
cell cycle
radiation induced
big data
cell proliferation
artificial intelligence
data analysis